4//SEC Filing
Aralez Pharmaceuticals Inc. 4
Accession 0001104659-17-032415
CIK 0001660719operating
Filed
May 11, 8:00 PM ET
Accepted
May 12, 9:52 PM ET
Size
7.5 KB
Accession
0001104659-17-032415
Insider Transaction Report
Form 4
Glickman Mark A
Chief Commercial Officer
Transactions
- Award
Common Shares, without par value
2017-05-11+80,163→ 255,913 total - Award
Employee Stock Option (right to buy)
2017-05-11+92,621→ 92,621 totalExercise: $1.56Exp: 2027-05-11→ Common Shares, without par value (92,621 underlying)
Footnotes (3)
- [F1]Restricted Stock Units granted pursuant to the Aralez Pharmaceuticals Inc. 2016 Amended and Restated Long-Term Incentive Plan, which vest in substantially equal annual installments over the three years immediately following the date of grant, subject to continued employment or service to the Company.
- [F2]Includes 58,380 shares of Common Stock and 197,533 Restricted Stock Units.
- [F3]The option vests as to 25% of the shares on May 11, 2018, and the remainder vests in substantially equal installments over the 36 months immediately following such date, subject to continued employment or service to the Company.
Documents
Issuer
Aralez Pharmaceuticals Inc.
CIK 0001660719
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001660719
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 9:52 PM ET
- Size
- 7.5 KB